chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Musculoskeletal pain, Myalgia, Pain in extremity, Rotator cuff syndrome
Clinical narrative: I had my vaccination on 10/07/2022. On 10/12/2022 I started having muscle pains. These pains were manifesting on both shoulders and at the top of my legs and buttocks. It was difficult for me to move and I would have to gradually get my legs moving. I had a lot of pain in my shoulders. I could move my arms to the front of my body and near. I could not reach behind me or up above me. I contacted my physician in 10/2022. I stopped taking the alopurinol and testosterone. I was sent for blood panel. I was then referred to specialist for Neurology. I had an MRI of my right shoulder as it was the most painful. I was also referred to other specialty care and they put electrodes on my legs and put pins in my knees. I am still being followed up with specialty care. I was recommended by Neurology to have steroid injections. This made a substantial difference and the pain went away. I was then seen for my left shoulder. There was no tear but they treated with the same treatment. I was instructed to start Physical Therapy which I was doing daily. My legs improved dramatically with the physical therapy. I have had 2 months of pain free but the pain has started to come back the last 6 weeks and getting worse. I conversed with my doctor in 04/2023 and I have started back up with daily appointments the physical therapy.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Aortic aneurysm, Chronic obstructive pulmonary disease, Hypotension, Hypoxia, Pulmonary embolism
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) I95.9 HYPOTENSION 2/24/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) R09.02 HYPOXIA 2/15/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 RECURRENT PULMONARY EMBOLISM I95.9 HYPOTENSION 2/24/2022 RECURRENT PULMONARY EMBOLISM R09.02 HYPOXIA 2/15/2022 RECURRENT PULMONARY EMBOLISM I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 UTI (URINARY TRACT INFECTION) I95.9 HYPOTENSION 2/24/2022 UTI (URINARY TRACT INFECTION) R09.02 HYPOXIA 2/15/2022 UTI (URINARY TRACT INFECTION)
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) I95.9 HYPOTENSION 2/24/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) R09.02 HYPOXIA 2/15/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 RECURRENT PULMONARY EMBOLISM I95.9 HYPOTENSION 2/24/2022 RECURRENT PULMONARY EMBOLISM R09.02 HYPOXIA 2/15/2022 RECURRENT PULMONARY EMBOLISM I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I95.9 HYPOTENSION 2/24/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART R09.02 HYPOXIA 2/15/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART I26.99 ACUTE PULMONARY EMBOLISM 3/14/2022 UTI (URINARY TRACT INFECTION) I95.9 HYPOTENSION 2/24/2022 UTI (URINARY TRACT INFECTION) R09.02 HYPOXIA 2/15/2022 UTI (URINARY TRACT INFECTION)
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Erythema, Ocular hyperaemia, Pruritus, Rash
Clinical narrative: My symptoms started on December 04, 2022 I experienced rash, itchiness, redness around eyes, redness and itchiness around the elbows. I was prescribed steroids for my symptoms.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Nerve conduction studies, Neuropathy peripheral, Pain, Paraesthesia
Clinical narrative: Peripheral neuropathy, no treatment,  continuous tingling in feet with occasional painful flare-ups, continuing so far since July 2022
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Angiopathy, Asthenia, Biopsy kidney abnormal, Blood creatinine increased, Blood glucose fluctuation
Clinical narrative: 81-year-old male patient of MD who presented with poor appetite, weakness, diarrhea and cough.  He tested positive for COVID-19. His background history include CKD stage IV/V, diabetes mellitus, CAD, chronic anemia, BPH, hyperlipidemia and skin cancer.   Diarrhea resolved  Colitis resolving  Noncontrast CT of the abdomen/pelvis with diffuse colonic thickening suggestive of colitis. In the setting of COVID-19 infection. C. difficile testing neg Loose stool is improved. He was on Zosyn, now discontinued. Imodium as needed.   Covid-19 Virus Infection COVID pneumonia Chronic respiratory failure - 2L Date of onset of symptoms: 2-26-2023 Symptoms present on admission: Cough, weakness, poor appetite. Date of covid positive test: 3-8-2023 Vaccination status: 2 shots and 1 booster Imaging: CXR with left lower interstitial opacities. Current oxygen requirements: 2 liters  Medical therapy: steroids stop dexamethasone Consultants following:ID Anticipated special isolation end date: 3/8/23 - d/w ID - now off Isolation. CXR on 3/8 with left lower lobe interstitial opacities suspicious for pneumonia.  Repeat CXR today.  .  Discussed with ID. No need for further antibiotics   CKD stage IV/V Had renal biopsy in 9/2022 with finding of advanced chronic changes in the setting of severe vascular disease with obliterative microvascular changes. No need for renal replacement therapy at present. Cr improved to 2.60 Nephrology following.as an OP   Generalized weakness Consult PT/OT and CM   Anemia of CKD and iron deficiency Follows with hematology and receives Venofer. Monitor Hb closely.   HTN He has a history of left renal artery stenosis status post stent. Also history of right subclavian stenosis. BP is now higher. Repeat CXR BP remains persistently elevated. Continue Norvasc and Coreg, increase dose of lisinopril. Increasing amlodipine to 10 mg Hydralazine as needed   Diabetes mellitus II Fluctuations in BG since yesterday. Likely component of IV steroid. Adjusted Lantus and SSI. Continue to monitor, avoid hypoglycemia.   Chronic respiratory failure Continue O2 support and bronchodilators. He uses O2 at home. Currently on 2 L.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic respiratory failure, Clostridium test negative
Clinical narrative: 81-year-old male patient of MD who presented with poor appetite, weakness, diarrhea and cough.  He tested positive for COVID-19. His background history include CKD stage IV/V, diabetes mellitus, CAD, chronic anemia, BPH, hyperlipidemia and skin cancer.   Diarrhea resolved  Colitis resolving  Noncontrast CT of the abdomen/pelvis with diffuse colonic thickening suggestive of colitis. In the setting of COVID-19 infection. C. difficile testing neg Loose stool is improved. He was on Zosyn, now discontinued. Imodium as needed.   Covid-19 Virus Infection COVID pneumonia Chronic respiratory failure - 2L Date of onset of symptoms: 2-26-2023 Symptoms present on admission: Cough, weakness, poor appetite. Date of covid positive test: 3-8-2023 Vaccination status: 2 shots and 1 booster Imaging: CXR with left lower interstitial opacities. Current oxygen requirements: 2 liters  Medical therapy: steroids stop dexamethasone Consultants following:ID Anticipated special isolation end date: 3/8/23 - d/w ID - now off Isolation. CXR on 3/8 with left lower lobe interstitial opacities suspicious for pneumonia.  Repeat CXR today.  .  Discussed with ID. No need for further antibiotics   CKD stage IV/V Had renal biopsy in 9/2022 with finding of advanced chronic changes in the setting of severe vascular disease with obliterative microvascular changes. No need for renal replacement therapy at present. Cr improved to 2.60 Nephrology following.as an OP   Generalized weakness Consult PT/OT and CM   Anemia of CKD and iron deficiency Follows with hematology and receives Venofer. Monitor Hb closely.   HTN He has a history of left renal artery stenosis status post stent. Also history of right subclavian stenosis. BP is now higher. Repeat CXR BP remains persistently elevated. Continue Norvasc and Coreg, increase dose of lisinopril. Increasing amlodipine to 10 mg Hydralazine as needed   Diabetes mellitus II Fluctuations in BG since yesterday. Likely component of IV steroid. Adjusted Lantus and SSI. Continue to monitor, avoid hypoglycemia.   Chronic respiratory failure Continue O2 support and bronchodilators. He uses O2 at home. Currently on 2 L.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Colitis, Computerised tomogram abdomen abnormal, Cough, Decreased appetite, Diarrhoea
Clinical narrative: 81-year-old male patient of MD who presented with poor appetite, weakness, diarrhea and cough.  He tested positive for COVID-19. His background history include CKD stage IV/V, diabetes mellitus, CAD, chronic anemia, BPH, hyperlipidemia and skin cancer.   Diarrhea resolved  Colitis resolving  Noncontrast CT of the abdomen/pelvis with diffuse colonic thickening suggestive of colitis. In the setting of COVID-19 infection. C. difficile testing neg Loose stool is improved. He was on Zosyn, now discontinued. Imodium as needed.   Covid-19 Virus Infection COVID pneumonia Chronic respiratory failure - 2L Date of onset of symptoms: 2-26-2023 Symptoms present on admission: Cough, weakness, poor appetite. Date of covid positive test: 3-8-2023 Vaccination status: 2 shots and 1 booster Imaging: CXR with left lower interstitial opacities. Current oxygen requirements: 2 liters  Medical therapy: steroids stop dexamethasone Consultants following:ID Anticipated special isolation end date: 3/8/23 - d/w ID - now off Isolation. CXR on 3/8 with left lower lobe interstitial opacities suspicious for pneumonia.  Repeat CXR today.  .  Discussed with ID. No need for further antibiotics   CKD stage IV/V Had renal biopsy in 9/2022 with finding of advanced chronic changes in the setting of severe vascular disease with obliterative microvascular changes. No need for renal replacement therapy at present. Cr improved to 2.60 Nephrology following.as an OP   Generalized weakness Consult PT/OT and CM   Anemia of CKD and iron deficiency Follows with hematology and receives Venofer. Monitor Hb closely.   HTN He has a history of left renal artery stenosis status post stent. Also history of right subclavian stenosis. BP is now higher. Repeat CXR BP remains persistently elevated. Continue Norvasc and Coreg, increase dose of lisinopril. Increasing amlodipine to 10 mg Hydralazine as needed   Diabetes mellitus II Fluctuations in BG since yesterday. Likely component of IV steroid. Adjusted Lantus and SSI. Continue to monitor, avoid hypoglycemia.   Chronic respiratory failure Continue O2 support and bronchodilators. He uses O2 at home. Currently on 2 L.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Iron deficiency anaemia, Lung opacity, Nephrogenic anaemia, SARS-CoV-2 test positive
Clinical narrative: 81-year-old male patient of MD who presented with poor appetite, weakness, diarrhea and cough.  He tested positive for COVID-19. His background history include CKD stage IV/V, diabetes mellitus, CAD, chronic anemia, BPH, hyperlipidemia and skin cancer.   Diarrhea resolved  Colitis resolving  Noncontrast CT of the abdomen/pelvis with diffuse colonic thickening suggestive of colitis. In the setting of COVID-19 infection. C. difficile testing neg Loose stool is improved. He was on Zosyn, now discontinued. Imodium as needed.   Covid-19 Virus Infection COVID pneumonia Chronic respiratory failure - 2L Date of onset of symptoms: 2-26-2023 Symptoms present on admission: Cough, weakness, poor appetite. Date of covid positive test: 3-8-2023 Vaccination status: 2 shots and 1 booster Imaging: CXR with left lower interstitial opacities. Current oxygen requirements: 2 liters  Medical therapy: steroids stop dexamethasone Consultants following:ID Anticipated special isolation end date: 3/8/23 - d/w ID - now off Isolation. CXR on 3/8 with left lower lobe interstitial opacities suspicious for pneumonia.  Repeat CXR today.  .  Discussed with ID. No need for further antibiotics   CKD stage IV/V Had renal biopsy in 9/2022 with finding of advanced chronic changes in the setting of severe vascular disease with obliterative microvascular changes. No need for renal replacement therapy at present. Cr improved to 2.60 Nephrology following.as an OP   Generalized weakness Consult PT/OT and CM   Anemia of CKD and iron deficiency Follows with hematology and receives Venofer. Monitor Hb closely.   HTN He has a history of left renal artery stenosis status post stent. Also history of right subclavian stenosis. BP is now higher. Repeat CXR BP remains persistently elevated. Continue Norvasc and Coreg, increase dose of lisinopril. Increasing amlodipine to 10 mg Hydralazine as needed   Diabetes mellitus II Fluctuations in BG since yesterday. Likely component of IV steroid. Adjusted Lantus and SSI. Continue to monitor, avoid hypoglycemia.   Chronic respiratory failure Continue O2 support and bronchodilators. He uses O2 at home. Currently on 2 L.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Coronary artery disease, Dependence on respirator, Hypotension, Ischaemic stroke
Clinical narrative: Pfizer vaccine was administered outside of Facility- reported by patient  I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 9/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 9/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I95.9 HYPOTENSION 5/21/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.00 ACUTE RESPIRATORY FAILURE 10/1/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 9/10/2021 THROMBOCYTOPENIA, UNSPECIFIED. I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 9/10/2021 THROMBOCYTOPENIA, UNSPECIFIED. I95.9 HYPOTENSION 5/21/2021 THROMBOCYTOPENIA, UNSPECIFIED. J96.00 ACUTE RESPIRATORY FAILURE 10/1/2021 THROMBOCYTOPENIA, UNSPECIFIED. J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/10/2021 THROMBOCYTOPENIA, UNSPECIFIED. I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 9/10/2021 RESPIRATOR DEPENDENCE I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 9/10/2021 RESPIRATOR DEPENDENCE I95.9 HYPOTENSION 5/21/2021 RESPIRATOR DEPENDENCE J96.00 ACUTE RESPIRATORY FAILURE 10/1/2021 RESPIRATOR DEPENDENCE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/10/2021 RESPIRATOR DEPENDENCE
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Lacunar stroke, Thrombocytopenia
Clinical narrative: Pfizer vaccine was administered outside of Facility- reported by patient  I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 9/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 9/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I95.9 HYPOTENSION 5/21/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.00 ACUTE RESPIRATORY FAILURE 10/1/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 9/10/2021 THROMBOCYTOPENIA, UNSPECIFIED. I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 9/10/2021 THROMBOCYTOPENIA, UNSPECIFIED. I95.9 HYPOTENSION 5/21/2021 THROMBOCYTOPENIA, UNSPECIFIED. J96.00 ACUTE RESPIRATORY FAILURE 10/1/2021 THROMBOCYTOPENIA, UNSPECIFIED. J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/10/2021 THROMBOCYTOPENIA, UNSPECIFIED. I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 9/10/2021 RESPIRATOR DEPENDENCE I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 9/10/2021 RESPIRATOR DEPENDENCE I95.9 HYPOTENSION 5/21/2021 RESPIRATOR DEPENDENCE J96.00 ACUTE RESPIRATORY FAILURE 10/1/2021 RESPIRATOR DEPENDENCE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/10/2021 RESPIRATOR DEPENDENCE
Age: 59.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Back pain, Blood test normal, COVID-19, Cough, Headache
Clinical narrative: I tested positive for COVID-19 on 4/10/23. I had a sore throat, body aches, sweats, headache, back pain, cough, and congestion. I contacted my doctor but was not prescribed medication. I have been taking ibuprofen, TYLENOL, and guaifenesin. I am still dealing with these symptoms at this time.
Age: 59.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Hyperhidrosis, Oropharyngeal pain, Pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on 4/10/23. I had a sore throat, body aches, sweats, headache, back pain, cough, and congestion. I contacted my doctor but was not prescribed medication. I have been taking ibuprofen, TYLENOL, and guaifenesin. I am still dealing with these symptoms at this time.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Blood culture negative, Blood lactic acid, COVID-19
Clinical narrative: Patient  is a 73 y.o. male patient of MD with history of CHF, chronic respiratory failure (3 L/min at baseline), COPD, DM 2, HTN, prostate cancer, paroxysmal A-fib, presented to Medical Center with shortness of breath found to have acute on chronic respiratory failure secondary to to COVID-19, COPD exacerbation and multifocal pneumonia   Acute on chronic respiratory failure with hypoxia and hypercapnia   Secondary to COVID, COPD exacerbation, PNA and pulmonary edema On 3L O2 NC at baseline, requiring BIPAP on admission Weaned to home 3L O2 NC BIPAP at bedtime Pulm following   Sepsis due to PNA, POA Multifocal Pneumonia Secondary to COVID-19 and Multifocal Pneumonia Afebrile, leukocytosis to 14.04k, lactate 2.0 CTPA (2/27) shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Urine antigens pending Blood cx NGTD Continue Rocephin/Azithro, transitioned to Levaquin to complete 7 day course   Covid-19 Virus Infection Date of onset of symptoms: 1 week ago Symptoms present on admission: Cough, sputum production, shortness of breath Date of covid positive test: 2/27 Vaccination status: vaccinated Imaging: CT imaging shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Oxygen requirements on admission: BiPAP Current oxygen requirements: 3L O2 NC (home requirement) Medical therapy: remdesivir, steroids, rocephin, and zithromax (changed to levaquin at discharge) Consultants following:  Pulm Anticipated special isolation end date: 3/5   COPD exacerbation Secondary to COVID-19, multifocal PNA Requiring BIPAP on admission, now weaned to home 3L O2 NC S/P Decadron, transitioned to prednisone with taper at discharge  Continue Symbicort and Duonebs   Acute on chronic HFrEF exacerbation  Medical noncompliance  Likely due to dietary non compliance Echo (2019) with EF 40-45% CT with findings of pulmonary edema Repeat echo (2/28) with EF 57% S/P IV lasix, transitioned to po lasix 40mg BID Continue home coreg, losartan, aldactone  Paroxysmal Atrial fibrillation Continue home Eliquis, carvedilol, sotalol Rate controlled   DM2 with hyperglycemia  A1C 8.6 Held home Glipizide Decreased home Lantus SSI   Hyperlipidemia Continue home lipitor
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cardiac failure, Cardiac failure acute, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Patient  is a 73 y.o. male patient of MD with history of CHF, chronic respiratory failure (3 L/min at baseline), COPD, DM 2, HTN, prostate cancer, paroxysmal A-fib, presented to Medical Center with shortness of breath found to have acute on chronic respiratory failure secondary to to COVID-19, COPD exacerbation and multifocal pneumonia   Acute on chronic respiratory failure with hypoxia and hypercapnia   Secondary to COVID, COPD exacerbation, PNA and pulmonary edema On 3L O2 NC at baseline, requiring BIPAP on admission Weaned to home 3L O2 NC BIPAP at bedtime Pulm following   Sepsis due to PNA, POA Multifocal Pneumonia Secondary to COVID-19 and Multifocal Pneumonia Afebrile, leukocytosis to 14.04k, lactate 2.0 CTPA (2/27) shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Urine antigens pending Blood cx NGTD Continue Rocephin/Azithro, transitioned to Levaquin to complete 7 day course   Covid-19 Virus Infection Date of onset of symptoms: 1 week ago Symptoms present on admission: Cough, sputum production, shortness of breath Date of covid positive test: 2/27 Vaccination status: vaccinated Imaging: CT imaging shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Oxygen requirements on admission: BiPAP Current oxygen requirements: 3L O2 NC (home requirement) Medical therapy: remdesivir, steroids, rocephin, and zithromax (changed to levaquin at discharge) Consultants following:  Pulm Anticipated special isolation end date: 3/5   COPD exacerbation Secondary to COVID-19, multifocal PNA Requiring BIPAP on admission, now weaned to home 3L O2 NC S/P Decadron, transitioned to prednisone with taper at discharge  Continue Symbicort and Duonebs   Acute on chronic HFrEF exacerbation  Medical noncompliance  Likely due to dietary non compliance Echo (2019) with EF 40-45% CT with findings of pulmonary edema Repeat echo (2/28) with EF 57% S/P IV lasix, transitioned to po lasix 40mg BID Continue home coreg, losartan, aldactone  Paroxysmal Atrial fibrillation Continue home Eliquis, carvedilol, sotalol Rate controlled   DM2 with hyperglycemia  A1C 8.6 Held home Glipizide Decreased home Lantus SSI   Hyperlipidemia Continue home lipitor
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Diet noncompliance, Dyspnoea, Echocardiogram normal, Ejection fraction normal
Clinical narrative: Patient  is a 73 y.o. male patient of MD with history of CHF, chronic respiratory failure (3 L/min at baseline), COPD, DM 2, HTN, prostate cancer, paroxysmal A-fib, presented to Medical Center with shortness of breath found to have acute on chronic respiratory failure secondary to to COVID-19, COPD exacerbation and multifocal pneumonia   Acute on chronic respiratory failure with hypoxia and hypercapnia   Secondary to COVID, COPD exacerbation, PNA and pulmonary edema On 3L O2 NC at baseline, requiring BIPAP on admission Weaned to home 3L O2 NC BIPAP at bedtime Pulm following   Sepsis due to PNA, POA Multifocal Pneumonia Secondary to COVID-19 and Multifocal Pneumonia Afebrile, leukocytosis to 14.04k, lactate 2.0 CTPA (2/27) shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Urine antigens pending Blood cx NGTD Continue Rocephin/Azithro, transitioned to Levaquin to complete 7 day course   Covid-19 Virus Infection Date of onset of symptoms: 1 week ago Symptoms present on admission: Cough, sputum production, shortness of breath Date of covid positive test: 2/27 Vaccination status: vaccinated Imaging: CT imaging shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Oxygen requirements on admission: BiPAP Current oxygen requirements: 3L O2 NC (home requirement) Medical therapy: remdesivir, steroids, rocephin, and zithromax (changed to levaquin at discharge) Consultants following:  Pulm Anticipated special isolation end date: 3/5   COPD exacerbation Secondary to COVID-19, multifocal PNA Requiring BIPAP on admission, now weaned to home 3L O2 NC S/P Decadron, transitioned to prednisone with taper at discharge  Continue Symbicort and Duonebs   Acute on chronic HFrEF exacerbation  Medical noncompliance  Likely due to dietary non compliance Echo (2019) with EF 40-45% CT with findings of pulmonary edema Repeat echo (2/28) with EF 57% S/P IV lasix, transitioned to po lasix 40mg BID Continue home coreg, losartan, aldactone  Paroxysmal Atrial fibrillation Continue home Eliquis, carvedilol, sotalol Rate controlled   DM2 with hyperglycemia  A1C 8.6 Held home Glipizide Decreased home Lantus SSI   Hyperlipidemia Continue home lipitor
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Glycosylated haemoglobin increased, Hyperglycaemia, Leukocytosis, Lung opacity, Malaise
Clinical narrative: Patient  is a 73 y.o. male patient of MD with history of CHF, chronic respiratory failure (3 L/min at baseline), COPD, DM 2, HTN, prostate cancer, paroxysmal A-fib, presented to Medical Center with shortness of breath found to have acute on chronic respiratory failure secondary to to COVID-19, COPD exacerbation and multifocal pneumonia   Acute on chronic respiratory failure with hypoxia and hypercapnia   Secondary to COVID, COPD exacerbation, PNA and pulmonary edema On 3L O2 NC at baseline, requiring BIPAP on admission Weaned to home 3L O2 NC BIPAP at bedtime Pulm following   Sepsis due to PNA, POA Multifocal Pneumonia Secondary to COVID-19 and Multifocal Pneumonia Afebrile, leukocytosis to 14.04k, lactate 2.0 CTPA (2/27) shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Urine antigens pending Blood cx NGTD Continue Rocephin/Azithro, transitioned to Levaquin to complete 7 day course   Covid-19 Virus Infection Date of onset of symptoms: 1 week ago Symptoms present on admission: Cough, sputum production, shortness of breath Date of covid positive test: 2/27 Vaccination status: vaccinated Imaging: CT imaging shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Oxygen requirements on admission: BiPAP Current oxygen requirements: 3L O2 NC (home requirement) Medical therapy: remdesivir, steroids, rocephin, and zithromax (changed to levaquin at discharge) Consultants following:  Pulm Anticipated special isolation end date: 3/5   COPD exacerbation Secondary to COVID-19, multifocal PNA Requiring BIPAP on admission, now weaned to home 3L O2 NC S/P Decadron, transitioned to prednisone with taper at discharge  Continue Symbicort and Duonebs   Acute on chronic HFrEF exacerbation  Medical noncompliance  Likely due to dietary non compliance Echo (2019) with EF 40-45% CT with findings of pulmonary edema Repeat echo (2/28) with EF 57% S/P IV lasix, transitioned to po lasix 40mg BID Continue home coreg, losartan, aldactone  Paroxysmal Atrial fibrillation Continue home Eliquis, carvedilol, sotalol Rate controlled   DM2 with hyperglycemia  A1C 8.6 Held home Glipizide Decreased home Lantus SSI   Hyperlipidemia Continue home lipitor
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pneumonia, Positive airway pressure therapy, Productive cough, Pulmonary oedema, Respiratory failure
Clinical narrative: Patient  is a 73 y.o. male patient of MD with history of CHF, chronic respiratory failure (3 L/min at baseline), COPD, DM 2, HTN, prostate cancer, paroxysmal A-fib, presented to Medical Center with shortness of breath found to have acute on chronic respiratory failure secondary to to COVID-19, COPD exacerbation and multifocal pneumonia   Acute on chronic respiratory failure with hypoxia and hypercapnia   Secondary to COVID, COPD exacerbation, PNA and pulmonary edema On 3L O2 NC at baseline, requiring BIPAP on admission Weaned to home 3L O2 NC BIPAP at bedtime Pulm following   Sepsis due to PNA, POA Multifocal Pneumonia Secondary to COVID-19 and Multifocal Pneumonia Afebrile, leukocytosis to 14.04k, lactate 2.0 CTPA (2/27) shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Urine antigens pending Blood cx NGTD Continue Rocephin/Azithro, transitioned to Levaquin to complete 7 day course   Covid-19 Virus Infection Date of onset of symptoms: 1 week ago Symptoms present on admission: Cough, sputum production, shortness of breath Date of covid positive test: 2/27 Vaccination status: vaccinated Imaging: CT imaging shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Oxygen requirements on admission: BiPAP Current oxygen requirements: 3L O2 NC (home requirement) Medical therapy: remdesivir, steroids, rocephin, and zithromax (changed to levaquin at discharge) Consultants following:  Pulm Anticipated special isolation end date: 3/5   COPD exacerbation Secondary to COVID-19, multifocal PNA Requiring BIPAP on admission, now weaned to home 3L O2 NC S/P Decadron, transitioned to prednisone with taper at discharge  Continue Symbicort and Duonebs   Acute on chronic HFrEF exacerbation  Medical noncompliance  Likely due to dietary non compliance Echo (2019) with EF 40-45% CT with findings of pulmonary edema Repeat echo (2/28) with EF 57% S/P IV lasix, transitioned to po lasix 40mg BID Continue home coreg, losartan, aldactone  Paroxysmal Atrial fibrillation Continue home Eliquis, carvedilol, sotalol Rate controlled   DM2 with hyperglycemia  A1C 8.6 Held home Glipizide Decreased home Lantus SSI   Hyperlipidemia Continue home lipitor
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sepsis, Treatment noncompliance, White blood cell count increased
Clinical narrative: Patient  is a 73 y.o. male patient of MD with history of CHF, chronic respiratory failure (3 L/min at baseline), COPD, DM 2, HTN, prostate cancer, paroxysmal A-fib, presented to Medical Center with shortness of breath found to have acute on chronic respiratory failure secondary to to COVID-19, COPD exacerbation and multifocal pneumonia   Acute on chronic respiratory failure with hypoxia and hypercapnia   Secondary to COVID, COPD exacerbation, PNA and pulmonary edema On 3L O2 NC at baseline, requiring BIPAP on admission Weaned to home 3L O2 NC BIPAP at bedtime Pulm following   Sepsis due to PNA, POA Multifocal Pneumonia Secondary to COVID-19 and Multifocal Pneumonia Afebrile, leukocytosis to 14.04k, lactate 2.0 CTPA (2/27) shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Urine antigens pending Blood cx NGTD Continue Rocephin/Azithro, transitioned to Levaquin to complete 7 day course   Covid-19 Virus Infection Date of onset of symptoms: 1 week ago Symptoms present on admission: Cough, sputum production, shortness of breath Date of covid positive test: 2/27 Vaccination status: vaccinated Imaging: CT imaging shows multifocal opacities L>R, pulmonary edema versus multifocal pneumonia Oxygen requirements on admission: BiPAP Current oxygen requirements: 3L O2 NC (home requirement) Medical therapy: remdesivir, steroids, rocephin, and zithromax (changed to levaquin at discharge) Consultants following:  Pulm Anticipated special isolation end date: 3/5   COPD exacerbation Secondary to COVID-19, multifocal PNA Requiring BIPAP on admission, now weaned to home 3L O2 NC S/P Decadron, transitioned to prednisone with taper at discharge  Continue Symbicort and Duonebs   Acute on chronic HFrEF exacerbation  Medical noncompliance  Likely due to dietary non compliance Echo (2019) with EF 40-45% CT with findings of pulmonary edema Repeat echo (2/28) with EF 57% S/P IV lasix, transitioned to po lasix 40mg BID Continue home coreg, losartan, aldactone  Paroxysmal Atrial fibrillation Continue home Eliquis, carvedilol, sotalol Rate controlled   DM2 with hyperglycemia  A1C 8.6 Held home Glipizide Decreased home Lantus SSI   Hyperlipidemia Continue home lipitor
Age: 0.33
Sex: M
Vaccine: RV1
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Rotarix not reconstituted; Diluent given without reconstitution; This non-serious case was reported by a other health professional and described the occurrence of inappropriate preparation of medication in a 4-month-old male patient who received Rota (Rotarix lyophilized formulation) (batch number KB7FJ) for prophylaxis.   On 09-FEB-2023, the patient received the 2nd dose of Rotarix lyophilized formulation (oral). On 09-FEB-2023, an unknown time after receiving Rotarix lyophilized formulation, the patient experienced inappropriate preparation of medication (Verbatim: Rotarix not reconstituted) and inappropriate dose of vaccine administered (Verbatim: Diluent given without reconstitution). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-Mar-2023 The reporter stated that, when performing the vaccine count it was noted there was 1 more vial of the live virus vial than the diluent syringe.  The reporter stated three patients had received doses so it was unclear if this patient received the correct dose. The case was linked with case US2023034036 and US2023AMR047918, reported by same reporter for different patients. The patient received diluent portion of Rotarix without reconstitution, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.; Sender's Comments:  US-GSK-US2023AMR047918:Same reporter US-GSK-US2023034036:Same reporter US-GSK-US2023034036:Same reporter
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal pain upper, Abdominal tenderness, Bacterial test, Diarrhoea, Gastrointestinal viral infection
Clinical narrative: I was having diarrhea that was very urgent and sudden. At first, I did not think too much of this but this lasted for a few weeks. By the second and third week I was having bad stomach cramping and pain with tenderness when you would touch my abdomen. I reached out to my health care provider on March 2nd and they took Stool samples which checked for parasites and bacteria which all came back negative. They then sent me to the gastroenterologist on March 14th. I was starting to get better at this point but I had a cold at the end of this and was having fevers with that cold. The Gastroenterologist thought that because of that I likely had virus as I was feeling better after the cold and the fever. They did put me on fiber and a probiotic.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Parasite stool test negative, Pyrexia
Clinical narrative: I was having diarrhea that was very urgent and sudden. At first, I did not think too much of this but this lasted for a few weeks. By the second and third week I was having bad stomach cramping and pain with tenderness when you would touch my abdomen. I reached out to my health care provider on March 2nd and they took Stool samples which checked for parasites and bacteria which all came back negative. They then sent me to the gastroenterologist on March 14th. I was starting to get better at this point but I had a cold at the end of this and was having fevers with that cold. The Gastroenterologist thought that because of that I likely had virus as I was feeling better after the cold and the fever. They did put me on fiber and a probiotic.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: Feeling sick; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling sick in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25-JAN-2023, the patient received the 1st dose of Shingrix (intramuscular). On 25-JAN-2023, less than a day after receiving Shingrix, the patient experienced feeling sick (Verbatim: Feeling sick). The outcome of the feeling sick was resolved.   It was unknown if the reporter considered the feeling sick to be related to Shingrix.     It was unknown if the company considered the feeling sick to be related to Shingrix.   Linked case(s) involving the same patient:  US2023049150   Additional Information: GSK receipt date: 03-APR-2023 The reporter himself reported that he had his first dose of Shingrix on 25-Jan-2023 and afterwards he felt sick.  The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023049150:Same reporter
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; This non-serious case was reported by a consumer via sales rep and described the occurrence of influenza-like symptoms in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.  Previously administered products included Shingrix with an associated reaction of no adverse event (Shingrix first shot was okay for patient).  On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: Flu like symptoms). The outcome of the influenza-like symptoms was resolved (duration 24 hrs).  It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  It was unknown if the company considered the influenza-like symptoms to be related to Shingrix.  Additional Information: GSK receipt date: 03-APR-2023 The patent was over age 50 years. The reporter said that, the second shot had resulted in flu like symptoms which had lasted for 24 hours.  The reporter had denied to provide further contact details.
Sex: U
Vaccine: VARZOS
Symptoms: Illness, Pain in extremity
Clinical narrative: Sick; Arm was sore for weeks; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Sick) and pain in arm (Verbatim: Arm was sore for weeks). The outcome of the sickness was not reported and the outcome of the pain in arm was resolved.   The reporter considered the sickness and pain in arm to be related to Shingles vaccine.     The company considered the sickness and pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 02-APR-2023 This case was reported by a patient via interactive digital media. The patient reported that the shingles vaccine sucked. The patient had never had a vaccine which made him or her sick and his or her arm was sore for weeks. Follow-up was not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Hurts so bad, arm hasn't recover; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Hurts so bad, arm hasn't recover). The outcome of the pain in arm was not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 03-APR-2023 This case was reported by a patient via interactive digital media. The patient shingles vaccine hurts so bad, so far his/ her arm had not recovered. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: FLUX
Symptoms: Pain
Clinical narrative: Painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, an unknown time after receiving Flu vaccine, the patient experienced pain (Verbatim: Painful). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Flu vaccine.     It was unknown if the company considered the pain to be related to Flu vaccine.   Linked case(s) involving the same patient:  US2023AMR050629   Additional Information: GSK Receipt Date: 16-MAR-2023 This case was reported by the patient via interactive digital media. The patient reported that he or she received flu shot and it was painful. This case had been linked with US2023AMR050629 by same reporter for same patient.  Follow-up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR050629:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal
Clinical narrative: Felt like I'd been in a car accident/Vaccinated and the shot is made for a horse; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 hr after receiving Shingles vaccine, the patient experienced feeling bad (Verbatim: Felt like I'd been in a car accident/Vaccinated and the shot is made for a horse). The outcome of the feeling bad was not reported.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.     It was unknown if the company considered the feeling bad to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 17-MAR-2023 This case was reported by a patient via interactive digital media. The patient vaccinated & the shot was made for a horse. within 1 hours patient felt like, she/ he will been in a car accident. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Joint swelling
Clinical narrative: Whole shoulder is swollen; Whole shoulder is painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of swollen joints in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced swollen joints (Verbatim: Whole shoulder is swollen) and shoulder pain (Verbatim: Whole shoulder is painful). The outcome of the swollen joints and shoulder pain were not reported.   It was unknown if the reporter considered the swollen joints and shoulder pain to be related to Shingles vaccine.     It was unknown if the company considered the swollen joints and shoulder pain to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 17-MAR-2023 This case was reported by a patient via interactive digital media. The patient just had a shingles shot and his/her whole shoulder was swollen and painful But, he/she reckon it's better than having shingles.  The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Malaise, Musculoskeletal pain
Clinical narrative: Extreme soreness in my shoulder blades; Felt ill I had don an extreme workout; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shoulder blade pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced shoulder blade pain (Verbatim: Extreme soreness in my shoulder blades) and unwell (Verbatim: Felt ill I had don an extreme workout). The outcome of the shoulder blade pain and unwell were not reported.   It was unknown if the reporter considered the shoulder blade pain and unwell to be related to Shingles vaccine.     It was unknown if the company considered the shoulder blade pain and unwell to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 17-MAR-2023 This case was reported by a patient via interactive digital media. The patient got 2nd shingles vaccine and cause extreme soreness in her/his shoulder blades felt ill. The patient had done an extreme workout with weights. The patient was very happy he/she did get it The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Feel pain for my 2nd shot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Feel pain for my 2nd shot). The outcome of the pain was resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 17-MAR-2023 This case was reported by a patient via interactive digital media. The patient feel pain for his/her 2nd shot for how many days. The patient stated that, thanks god he/she ok now. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal
Clinical narrative: Feel like you got hit by a truck; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced feeling bad (Verbatim: Feel like you got hit by a truck). The outcome of the feeling bad was not reported.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.     It was unknown if the company considered the feeling bad to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 17-MAR-2023 This case was reported by a patient via interactive digital media. The patient highly recommend to get the vaccine the day before you have a day off, especially the 2nd one. The patient stated that, you may feel like you got hit by a truck. The patient give this advice to everyone and they have all thanked her/him after they got the vaccine. still better than shingles tho. The follow-up could not be possible as no contact details were available.